Izotropic Corporation (OTCMKTS:IZOZF – Get Free Report) was the recipient of a large decline in short interest during the month of October. As of October 30th, there was short interest totaling 9,609 shares, a decline of 89.6% from the October 15th total of 92,598 shares. Based on an average daily trading volume, of 67,127 shares, the short-interest ratio is currently 0.1 days. Approximately 0.0% of the shares of the stock are short sold.
Izotropic Stock Performance
Shares of OTCMKTS IZOZF opened at $0.10 on Wednesday. Izotropic has a 12-month low of $0.07 and a 12-month high of $0.29. The firm’s 50-day moving average price is $0.13 and its 200-day moving average price is $0.17.
Izotropic (OTCMKTS:IZOZF – Get Free Report) last released its quarterly earnings results on Monday, September 28th. The company reported ($0.01) EPS for the quarter, missing the consensus estimate of $0.01 by ($0.02). Analysts anticipate that Izotropic will post 0.03 earnings per share for the current fiscal year.
About Izotropic
Izotropic Corporation is a medical technology company focused on developing dedicated breast computed tomography (CT) imaging systems. Its principal product is the IzoView breast CT system, designed to produce three-dimensional images of the breast without the compression typically used in conventional mammography. The company’s technology is intended to support breast-cancer screening and diagnostic imaging by providing detailed volumetric images that may help clinicians evaluate breast tissue and abnormalities.
See Also
- Five stocks we like better than Izotropic
- Poll Reveals: Which States Are Most Prepared for a Crisis? [2026]
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
Receive News & Ratings for Izotropic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Izotropic and related companies with MarketBeat.com's FREE daily email newsletter.
